Back

Exploring in vitro markers of potency of extracellular vesicles from cardiosphere-derived cells in the treatment of cardiac ageing

26 August 2022 (14:15 - 14:55)
Organised by:
Congress Presentation Part of: Ageing, cellular senescence and cardiovascular diseases Gene Therapy, Cell Therapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Ms Lidia Gomez-Cid

University Hospital Gregorio Maranon, Madrid (Spain)

5 More presentations in this session

Presentation thumbnail
Crosstalk between NADPH oxidases and the Hippo pathway coactivator Yes-Associated Protein promotes the cardiac response to hypoxia
Mrs X. Chen (Munich, DE)
Abstract Slides
Presentation thumbnail
Senolytics rejuvenate the reparative activity of human cardiomyocytes and endothelial cells
Professor G. Ellison-Hughes (London, GB)
Abstract Slides
Presentation thumbnail
Telomere shortening in hypertensive heart disease depends on NOX2-mediated loss of PRDX1 and oxidative DNA damage
Doctor M. Brandt (Mainz, DE)
Abstract Slides
Presentation thumbnail
Formation of human cardiomyocytes is impaired by fibroblastic paracrine signalling: breaking down the mechanisms involved in rebuilding the heart
Doctor A. Ramkisoensing (Leiden, NL)
Abstract Slides
Presentation thumbnail
Differential endothelial senescence elicited by AQP1 regulation of epigenetic/metabolic responses
Doctor S. Saeedi (Schlieren, CH)
Abstract Slides

Access the full session

Session thumbnail
Ageing, cellular senescence and cardiovascular diseases

The Event

Event poster

ESC Congress 2022

26 August 2022 14:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources